Showing results (1601-1610 of 6,962) with videos related to
Sort By:
Pageof 697
Journal of Clinical Pharmacology|April 29, 1998
Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsyR C Sachdeo, S Narang-Sachdeo, P A Montgomery, et al.Journal of Clinical Pharmacology|April 29, 1998
Clinical endoscopic evaluation of the gastroduodenal tolerance to (R)- ketoprofen, (R)- flurbiprofen, racemic ketoprofen, and paracetamol: a randomized, single-blind, placebo-controlled trialT P Jerussi, J F Caubet, J E McCray, et al.Journal of Clinical Pharmacology|April 29, 1998
Ignorability and parameter estimation in longitudinal pharmacokinetic studiesE I Ette, H Sun, T M LuddenJournal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft functionL M Shaw, R Mick, I Nowak, et al.Journal of Clinical Pharmacology|January 1, 1987
Metabolism of desciclovir, a prodrug of acyclovir, in humans after multiple oral dosingH C Krasny, B G PettyJournal of Clinical Pharmacology|February 1, 1987
Pharmacokinetics and pharmacodynamic effects of aqueous diltiazem in healthy humansM Fu, J S Hung, S J Yeh, et al.Journal of Clinical Pharmacology|February 1, 1987
The polymorphic metabolism of dextromethorphanJ R Woodworth, S R Dennis, L Moore, et al.Journal of Clinical Pharmacology|January 1, 1986
Verapamil pharmacodynamics after intravenous and oral dosing: theoretic considerationW A Colburn, R K Brazzell, A A HolazoJournal of Clinical Pharmacology|February 1, 1986
Postburn serum drug binding and serum protein concentrationsD C Bloedow, J F Hansbrough, T Hardin, et al.Journal of Clinical Pharmacology|August 20, 2025
Clinical Impact of Hepatic Impairment on the Pharmacokinetics of Sotorasib and its Major Metabolites: Implications for Dose AdjustmentMason McComb, Panli Cardona, Caitlin Sampson, et al.Pageof 697